Zobrazeno 1 - 10
of 1 321
pro vyhledávání: '"Gladman, DD"'
Autor:
Merola, JF, Landewé, R, McInnes, IB, Mease, PJ, Ritchlin, CT, Tanaka, Y, Asahina, A, Behrens, F, Gladman, DD, Gossec, L, Gottlieb, AB, Thaçi, D, Warren, RB, Ink, B, Assudani, D, Bajracharya, R, Shende, V, Coarse, J, Coates, LC
Publikováno v:
The Lancet, 401(10370), 38-48. Elsevier Limited
Background: Bimekizumab is a monoclonal IgG1 antibody that selectively inhibits interleukin (IL)-17F and IL-17A. This study compared the efficacy and safety of bimekizumab with placebo over 16 weeks in patients with active psoriatic arthritis and pre
Autor:
Ng, B, Jadon, D, Adebajo, A, Ayan, G, Callis Duffin, K, Chandran, V, Coates, LC, D’Agostino, MA, de Vlam, K, Deodhar, A, Eder, L, Garg, A, Gladman, DD, Goel, N, Gottlieb, A, Husni, ME, Katz, A, Kavanaugh, A, Lubrano, E, Mease, P, Merola, J, Nash, P, Ogdie, A, Pennington, S, Perez-Chada, LM, Proft, F, Rosen, CF, Savage, L, Goldenstein-Schainberg, C, Siebert, S, Soriano, E, Steinkoenig, I, Tillett, W, Armstrong, A, FitzGerald, O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::96a2a3e87422fd4f0c5f57160ef207b2
https://ora.ox.ac.uk/objects/uuid:5163cd37-c34d-44a9-afdd-a352d54bd150
https://ora.ox.ac.uk/objects/uuid:5163cd37-c34d-44a9-afdd-a352d54bd150
Autor:
Leung, Y-Y, Tillett, W, de Wit, M, Orbai, A-M, Coates, LC, FitzGerald, O, Helliwell, PS, Strand, V, Mease, P, Goel, N, Christensen, R, Merola, JF, Lindsay, C, Ogdie, A, Gossec, L, Gladman, DD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::d2ea35dfb7c75a9c914694d7fa84794e
https://ora.ox.ac.uk/objects/uuid:8140d0a2-c340-4be9-8f90-b05ec031ebb4
https://ora.ox.ac.uk/objects/uuid:8140d0a2-c340-4be9-8f90-b05ec031ebb4
Publikováno v:
Open Access Rheumatology: Research and Reviews, Vol Volume 9, Pp 1-9 (2016)
Konstantinos Tselios, Dafna D Gladman, Murray B Urowitz, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto, ON, Canada Abstract: Systemic lupus erythematosus (SLE) is charac
Externí odkaz:
https://doaj.org/article/2be12be71c584846b503667374ac2088
Autor:
Strand, V, Kaeley, GS, Bergman, MJ, Gladman, DD, Coates, LC, Sherif, B, Hur, P, Parikh, B, Gilloteau, I, Mease, PJ
Publikováno v:
The Lancet Rheumatology. 4:e208-e219
Background: The phase 3 FUTURE 5 trial (NCT02404350) showed the clinical and radiographical efficacy of secukinumab in patients with psoriatic arthritis. This analysis aimed to assess the effect of secukinumab on patient-reported outcomes (PROs). Met
Autor:
Mease, PJ, Gladman, DD, Ogdie, A, Coates, LC, Behrens, F, Kavanaugh, A, Mcinnes, I, Queiro, R, Guerette, B, Brunori, M, Teng, L, Smolen, JS
Objective: To evaluate the probability of achieving Clinical Disease Activity for Psoriatic Arthritis (cDAPSA) treatment targets of remission (REM) or low disease activity (LDA) with apremilast based on disease activity categories and corresponding r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::4a79355d4a515e471d2994d8712e5673
https://doi.org/10.1002/acr.24134
https://doi.org/10.1002/acr.24134
Publikováno v:
Lupus. Oct2014, Vol. 23 Issue 11, p1142-1148. 7p. 1 Color Photograph, 3 Charts, 1 Graph.
Autor:
Højgaard, P, Klokker, L, Orbai, A-M, Holmsted, K, Bartels, EM, Leung, YY, Goel, N, de Wit, M, Gladman, DD, Mease, P, Dreyer, L, Kristensen, LE, FitzGerald, O, Tillett, W, Gossec, L, Helliwell, P, Strand, V, Ogdie, A, Terwee, CB, Christensen, R
Background: An updated psoriatic arthritis (PsA) core outcome set (COS) for randomized controlled trials (RCTs) was endorsed at the Outcome Measures in Rheumatology (OMERACT) meeting in 2016. Objectives: To synthesize the evidence on measurement prop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::9be5c1b2e956c38c92b33dbc642d135a
https://eprints.whiterose.ac.uk/121202/1/1-s2.0-S0049017217301828-main.pdf
https://eprints.whiterose.ac.uk/121202/1/1-s2.0-S0049017217301828-main.pdf
Publikováno v:
Lupus. Oct2013, Vol. 22 Issue 12, p1243-1250. 8p. 1 Chart.